Neutralising Antibodies against Enterovirus and Parechovirus in IVIG Reflect General Circulation: A Tool for Sero-Surveillance.
Enterovirus
Parechovirus
sero-surveillance
surveillance
virus neutralisation assay
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
29 05 2021
29 05 2021
Historique:
received:
23
04
2021
revised:
17
05
2021
accepted:
25
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
28
1
2022
Statut:
epublish
Résumé
Non-polio enteroviruses (NPEV) and parechoviruses (PeV) are widespread pathogens that cause significant morbidity. Surveillance is based on culturing or genotyping of virus strains found in clinical samples. Sero-surveillance, by measuring neutralising antibodies (nAb) through virus neutralisation assays (VNA), could provide additional information as it offers a more comprehensive overview of exposure to circulating types in the general population. In our study we evaluated Intravenous immunoglobulins (IVIG) to generate sero-surveillance data. We performed VNA of nineteen NPEV and PeV with Dutch IVIG batches from two different time points (2010 and 2017) and an IVIG batch from Vietnam (2011). We compared our findings with geno- and sero-surveillance data and evaluated changes over time and between the two countries. Our findings show a good correlation with what is known from geno-surveillance data. The highest nAb titres were found against strains from
Identifiants
pubmed: 34072486
pii: v13061028
doi: 10.3390/v13061028
pmc: PMC8228535
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Immunoglobulins, Intravenous
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Science. 2018 Aug 24;361(6404):800-803
pubmed: 30139872
Antivir Ther. 2012;17(3):459-66
pubmed: 22293148
Emerg Microbes Infect. 2018 Jan 10;7(1):2
pubmed: 29323107
Scand J Infect Dis. 1986;18(4):287-94
pubmed: 3764348
Virol J. 2015 Nov 25;12:199
pubmed: 26607060
J Infect. 2016 Feb;72(2):223-32
pubmed: 26550926
Eur J Pediatr. 2016 Aug;175(8):1023-9
pubmed: 27156106
Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1525-31
pubmed: 23780695
Virology. 2012 Feb 5;423(1):49-57
pubmed: 22177700
J Med Virol. 1997 Nov;53(3):273-6
pubmed: 9365895
Virol J. 2013 Sep 11;10:280
pubmed: 24025733
J Clin Virol. 2013 Sep;58(1):211-5
pubmed: 23891146
Euro Surveill. 2016 Sep 29;21(39):
pubmed: 27719752
World J Pediatr. 2017 Dec;13(6):611-614
pubmed: 28766163
Euro Surveill. 2014 Nov 20;19(46):
pubmed: 25425513
Sci Rep. 2017 Sep 21;7(1):12075
pubmed: 28935894
Intervirology. 1980;12(6):329-34
pubmed: 6244237
Emerg Infect Dis. 2019 Jan;25(1):148-152
pubmed: 30561318
Emerg Infect Dis. 2016 Sep;22(9):1562-9
pubmed: 27533024
Curr Opin Infect Dis. 2015 Oct;28(5):479-87
pubmed: 26203854
Emerg Infect Dis. 2021 Jun;27(6):1616-1626
pubmed: 34013874
J Gen Virol. 2017 Jun;98(6):1145-1158
pubmed: 28631594
J Virol. 2014 Mar;88(5):2374-84
pubmed: 24371050
Emerg Infect Dis. 2019 Jun;25(6):1200-1203
pubmed: 30855226
Euro Surveill. 2019 Aug;24(35):
pubmed: 31481149